These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 123858)

  • 21. Suppression of pentylenetetrazol-induced seizures by hydralazine associated with 5-hydroxytryptaminergic system in rat brain.
    Hara S; Satoh T; Kitagawa H
    Jpn J Pharmacol; 1987 Apr; 43(4):361-8. PubMed ID: 2441099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of amantadine on motility of reserpinized mice as a function of brain biogenic amines and mouse strains.
    Messiha FS
    Brain Res Bull; 1989; 23(4-5):267-71. PubMed ID: 2590838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of 5-hydroxytryptamine in the analgesic action of pethidine and morphine in mice.
    Botting R; Morinan A
    Br J Pharmacol; 1982 Apr; 75(4):579-85. PubMed ID: 6175370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.
    Colpaert FC
    Neuropharmacology; 1987 Sep; 26(9):1431-40. PubMed ID: 3670563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reserpine, para-chlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferret.
    Barnes JM; Barnes NM; Costall B; Naylor RJ; Tattersall FD
    Neuropharmacology; 1988 Aug; 27(8):783-90. PubMed ID: 2905784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The failure of p-chlorophenylalanine to affect voluntary alcohol consumption in rats.
    Holman RB; Hoyland V; Shillito EE
    Br J Pharmacol; 1975 Feb; 53(2):299-304. PubMed ID: 125129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin in the control of the sleep-like states in frogs.
    Popova NK; Lobacheva II; Karmanova IG; Shilling NV
    Pharmacol Biochem Behav; 1984 May; 20(5):653-7. PubMed ID: 6204342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Audiogenic seizures in mice: influence of agents affecting brain serotonin.
    Alexander GJ; Kopeloff LM
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):437-48. PubMed ID: 134436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of rat brain 5-hydroxytryptamine metabolism by sublethal doses of organophosphate agents.
    Prioux-Guyonneau M; Coudray-Lucas C; Coq HM; Cohen Y; Wepierre J
    Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):278-84. PubMed ID: 6184944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of benzodiazepines and other anticonvulsant drugs on synthesis and utilization of 5-HT in mouse brain.
    Pratt JA; Jenner P; Marsden CD
    Neuropharmacology; 1985 Jan; 24(1):59-68. PubMed ID: 2580249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of alpha-adrenolytics on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rat's brain.
    Zebrowska-Lupina I; Kleinrok Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):241-5. PubMed ID: 1713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 35. Veratramine-induced behavior associated with serotonergic hyperfunction in mice.
    Nagata R; Izumi K
    Jpn J Pharmacol; 1991 Jan; 55(1):129-37. PubMed ID: 1710297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoamines and the mechanisms of action of antitussive drugs in rats.
    Kamei J; Ogawa M; Kasuya Y
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):117-27. PubMed ID: 2965557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Altagracia M; Rojas P; Kravzov J; Rios C
    Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin E1 causes sedation and increases 5-hydroxytryptamine turnover in rat brain.
    Haubrich DR; Perez-Cruet J; Reid WD
    Br J Pharmacol; 1973 May; 48(1):80-7. PubMed ID: 4269288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Action mechanism of anticonvulsant and anti-immobility (forced swim) effects of 3', 4'-dihydro-N, N-dimethylspiro-[9H-fluorene-9, 2' (5'H) furane]-3'-methanamine (AE37F)].
    Vamvakidès A; Antoniou K; Daïfoti Z
    Ann Pharm Fr; 2004 Jan; 62(1):49-55. PubMed ID: 14747773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G; Fernando JC; Marsden CA
    Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.